Disease Target (Biopharmaceuticals) Equipment
-
based in USA
Genome editing is efficient, precise and scalable. CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These ...
-
based in GERMANY
GENIMAPS® and GENISYST® technology integration facilitates Ai-driven target identification, and direct therapeutic interrogation of RNAi disease targets in vitro (2D and 3D), and in small and large animal models. This coupled workflow enables efficient and accelerated RNAi target discovery and efficacy ...
-
Manufactured by Lanthio Pharma BVbased in NETHERLANDS
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by ...
-
Manufactured by BioArctic ABbased in SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
-
by DEARGEN Inc.based in SOUTH KOREA
WX presents biomarkers, based on raw transcriptome data. It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
-
Manufactured by Lumen Bioscience, Inc.based in USA
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our ...
-
by DEARGEN Inc.based in SOUTH KOREA
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
-
Manufactured by Roche Diagnostics International AGbased in SWITZERLAND
The XT-8 system is the pioneer of true multiplex molecular testing, offering post-PCR detection for infectious disease, genetics, and pharmacogenetics ...
-
based in CANADA
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing ...
-
Manufactured by Symberix, Inc.based in USA
Trillions of microorganisms colonize the human body and play a central role in health and disease. Symbiotic drugs target bacteria to improve human health while leaving good microbes ...
-
based in USA
At Kephera, we are developing rapid tests for infectious diseases using novel immunochemistry in point-of-care format. Our proprietary assay technology is based on principles of particle interaction combined with a simple device, which together enable rapid detection of specific antibodies or antigens associated with the target ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
Our proprietary, miniaturized x-ray source is isotope-free and operates at 50 kV to deliver high dose rate, low energy radiation. The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...
-
Manufactured by NexImmune, Inc.based in USA
The injectable modality (AIM INJ) is an injectable pharmaceutical product of AIM nanoparticles decorated with antigen-specific peptides and co-stimulatory molecules appropriate for the disease being targeted. Based on specific size and bio-distribution characteristics, the AIM™ nanoparticles have the ability to engage antigen-specific T ...
-
Manufactured by SQZ Biotech, Inc.based in USA
Activating Antigen Carriers (AACs) are designed to transport disease-specific antigens and adjuvant cargo to a patient’s professional antigen presenting cells. The activated antigen presenting cells then prime immune cells to target disease. ...
-
Manufactured by Bioneer Corporationbased in SOUTH KOREA
ExiStation™ Universal Molecular Diagnostic System is an innovative semi-automated real-time qPCR based molecular diagnostic system. ExiStation™ is a workflow platform consisting of Max. 3 ExiPrep™ 16 Dx and one Exicycler™ 96. This unique composition allows simultaneous diagnosis of various diseases regardless of ...
-
Manufactured by AlloVirbased in USA
ALVR106 is an allogeneic, off-the-shelf, multi-virus specific VST therapy candidate designed to target diseases caused by the respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). ...
-
Manufactured by DermBiont, Inc.based in USA
leverage cutting edge innovation in dermatology and proprietary technology to efficiently develop targeted small molecule therapeutics and novel microbiome-based therapeutics for dermatologic indications that address the root cause of skin diseases. Our in-house discovery platform for microbiome-based therapeutics is enabled by terabytes of ...
-
Manufactured by G3T Therapeuticsbased in USA
All drugs targeting cardiovascular disease currently on the market work by lowering cholesterol levels. G3T identified and genetically validated an entirely novel biological mechanism and potential drug target that treats both cardiovascular disease, as well as non-alcoholic fatty liver disease. This is an ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you